A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.

Hellmut Samonigg; Martini Truschnig-Wilders; I Kuss; R Plot; Herbert Stöger; Marianne Schmid; Thomas Bauernhofer; Andreas Tiran; Thomas Pieber; L Havelec; H Loibner

doi:10.1097/00002371-199911000-00002

A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.

Hellmut Samonigg^* (Erstautor*in)
, Martini Truschnig-Wilders
, I Kuss
, R Plot
, Herbert Stöger
, Marianne Schmid
, Thomas Bauernhofer
, Andreas Tiran
, Thomas Pieber
, L Havelec
, H Loibner

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinische Abteilung für Onkologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

24 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Journal of Immunotherapy
DOIs	https://doi.org/10.1097/00002371-199911000-00002
Publikationsstatus	Veröffentlicht - 1999

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

302 Klinische Medizin
305 Andere Humanmedizin, Gesundheitswissenschaften
301 Medizinisch-theoretische Wissenschaften, Pharmazie

Zugriff auf Dokument

10.1097/00002371-199911000-00002

Andere Dateien und Links

Dieses zitieren

Samonigg, H., Truschnig-Wilders, M., Kuss, I., Plot, R., Stöger, H., Schmid, M., Bauernhofer, T., Tiran, A., Pieber, T., Havelec, L., & Loibner, H. (1999). A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer. Journal of Immunotherapy. https://doi.org/10.1097/00002371-199911000-00002

@article{6f001bad24bf43d1beddb3d92b5c7f44,

title = "A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.",

author = "Hellmut Samonigg and Martini Truschnig-Wilders and I Kuss and R Plot and Herbert St{\"o}ger and Marianne Schmid and Thomas Bauernhofer and Andreas Tiran and Thomas Pieber and L Havelec and H Loibner",

year = "1999",

doi = "10.1097/00002371-199911000-00002",

language = "English",

journal = "Journal of Immunotherapy",

issn = "1524-9557",

publisher = "Lippincott Williams and Wilkins",

}

Samonigg, H, Truschnig-Wilders, M, Kuss, I, Plot, R, Stöger, H, Schmid, M, Bauernhofer, T, Tiran, A, Pieber, T, Havelec, L & Loibner, H 1999, 'A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.', Journal of Immunotherapy. https://doi.org/10.1097/00002371-199911000-00002

TY - JOUR

T1 - A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.

AU - Truschnig-Wilders, Martini

AU - Kuss, I

AU - Plot, R

AU - Stöger, Herbert

AU - Schmid, Marianne

AU - Bauernhofer, Thomas

AU - Tiran, Andreas

AU - Pieber, Thomas

AU - Havelec, L

AU - Loibner, H

A2 - Samonigg, Hellmut

PY - 1999

Y1 - 1999

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000083516700002

UR - https://pubmed.ncbi.nlm.nih.gov/10570746

U2 - 10.1097/00002371-199911000-00002

DO - 10.1097/00002371-199911000-00002

M3 - Research article

C2 - 10570746

SN - 1524-9557

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

ER -